Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Magellan Health (MGLN)

Magellan Health (MGLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Magellan Health 4801 E. WASHINGTON ST PHOENIX AZ 85034 USA

www.magellanhealth.com P: 800-642-1716

Description:

Magellan Health Inc. is an American for-profit managed health care company, focused on behavioral healthcare. As a specialty health care manager, they focus on some of today's most complex and costly health care services. The depth and breadth of experience in managing behavioral health care, diagnostic imaging, specialty pharmaceutical services and providing pharmacy benefits administration enables us to deliver invaluable insights and innovative solutions that positively impact both the quality and the cost of some of the nation's fastest growing areas of health care. Maintaining the highest level of integrity and clinical and quality excellence have long been Magellan hallmarks. By working together with health plans, employers, government agencies, consumers, service providers, fellow employees and many other stakeholders, they get a full perspective of the situation and are able to leverage these partnerships to deliver effective and innovative solutions.

Key Statistics

Overview:

Market Capitalization, $K 2,501,277
Shares Outstanding, K 26,332
Annual Sales, $ 4,578 M
Annual Net Income, $ 382,340 K
Last Quarter Sales, $ 1,254 M
Last Quarter Net Income, $ 5,940 K
60-Month Beta 1.03
% of Insider Shareholders 14.10%
% of Institutional Shareholders 99.52%
Float, K 22,619
% Float 85.90%

Growth:

1-Year Return 14.67%
3-Year Return 56.05%
5-Year Return 20.62%
5-Year Revenue Growth -0.43%
5-Year Earnings Growth -36.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.03 on 11/05/21
Next Earnings Date 02/25/22
Earnings Per Share ttm 1.09
EPS Growth vs. Prev Qtr -72.73%
EPS Growth vs. Prev Year -62.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MGLN Ratios

Ratio
Price/Earnings ttm 87.15
Price/Earnings forward 27.86
Price/Earnings to Growth N/A
Return-on-Equity % 1.81%
Return-on-Assets % 1.05%
Profit Margin % 8.35%
Debt/Equity 0.27
Price/Sales 0.52
Price/Cash Flow 17.06
Price/Book 1.29
Book Value/Share 73.45
Interest Coverage -0.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar